What difficulties do Indian investors face when entering the Russian pharmaceutical market, and how can the TIME Forum help solve this problem?

During the live broadcast "In the New Year with Tatarstan: What Lies Ahead in 2026," Taliya Minullina, Chief Executive of the Tatarstan Investment Development Agency, discussed the challenges faced by Indian investors in the Russian pharmaceutical market and the role of the TIME Forum in addressing these issues.

"In order for a medicine to be brought to our market from abroad, it must go through a very complicated procedure. We have brought several investors who want to develop pharmaceuticals, but it can take 3-5 years of very complex approvals. Tatkhimfarmpreparaty has partners in India. When we held the first Russian-Indian forum, their partners from India and other Indian pharmaceutical companies attended. I believe that we should work together," said Taliya Minullina.